Circadian rhythm — light timing, body temperature, the master clock.
The suprachiasmatic nucleus runs a roughly 24-hour oscillator that is entrained by light at the retina and read out at the skin as a body temperature curve. Get the inputs right and sleep onset becomes a consequence, not a struggle. Get them wrong and no supplement closes the gap.
- The SCN, the master clock, and what entrainment means
- Light — the dominant zeitgeber, dose-response, timing
- Core body temperature as the master switch
- DLMO — the cleanest circadian phase marker
- A protocol stack with the strongest RCT support
- Phase-shift therapeutics — melatonin, light, sleep
- A tiered framework
- References
The SCN, the master clock, and what entrainment means
The SCN (suprachiasmatic nucleus) is a paired structure of roughly 20,000 neurons in the anterior hypothalamus, sitting just above the optic chiasm. It is the body's master circadian pacemaker. Lesion the SCN in a mammal and the circadian organization of behavior, body temperature, hormone release, and metabolism collapses [Hastings 2018].
The SCN runs an endogenous oscillator with a free-running period of approximately 24.2 hours in most adults. The slight mismatch with the 24-hour solar day is corrected daily by environmental cues called zeitgebers (German for "time-givers"). Light at the retina is the dominant zeitgeber. Meal timing, social cues, exercise, and ambient temperature are secondary inputs. When the SCN is properly entrained, the downstream peripheral clocks in liver, gut, muscle, and adipose tissue stay synchronized to it. When the SCN drifts out of phase with the solar day — shift work, transmeridian travel, chronic late-night bright light exposure — the peripheral clocks decouple, and the downstream metabolic, immune, and cognitive consequences are measurable.
The mechanism of light entrainment is now well-mapped. A subset of retinal ganglion cells expressing the photopigment melanopsin (ipRGCs — intrinsically photosensitive retinal ganglion cells) projects directly to the SCN via the retinohypothalamic tract. These cells are most sensitive to short-wavelength light in the 460-480 nm range (the blue end of the visible spectrum) and respond on a much slower timescale than rod-and-cone vision [Berson 2002]. They are the photoreceptor system that tells your hypothalamus what time of day it is, independent of what your visual cortex is doing.
Light — the dominant zeitgeber, dose-response, timing
The phase response curve (PRC) to light is the single most useful framework in practical circadian work. Khalsa and colleagues published the canonical human PRC using 6.7-hour bright light pulses; subsequent work has produced PRCs for 1-hour pulses and for light intensities spanning indoor (~200 lux) to outdoor sunlight (>10,000 lux) [Khalsa 2003] [St Hilaire 2012].
The shape of the curve is consistent. Light delivered before the core body temperature minimum (typically 2-3 hours before habitual wake time) phase-delays the circadian system — pushes the rhythm later. Light delivered after the core body temperature minimum phase-advances the system — pulls the rhythm earlier. Light delivered in the biological middle of the subjective day produces little phase shift. In practical terms: morning light advances; evening light delays. The magnitude of the shift is dose-dependent on both intensity and duration.
Intensity matters in a non-linear way. A typical indoor room reads 100-300 lux at eye level. An overcast morning outdoors reads 5,000-10,000 lux. Direct sunlight reads 50,000-100,000 lux. The biological response is logarithmic, not linear — meaning a 10-minute outdoor walk on a cloudy morning delivers more SCN signal than an hour in front of a well-lit kitchen window. This is the single most underestimated number in popular circadian writing.
The duration-response is similarly non-linear. A 1-hour pulse of bright light produces a peak-to-trough phase shift of roughly 2.2 hours across the curve — roughly 40% of what a 6.7-hour pulse produces, despite representing 15% of the exposure duration [St Hilaire 2012]. The first 10-15 minutes of morning light exposure deliver a disproportionate share of the entrainment signal. After roughly an hour the marginal return drops sharply.
Indoor light is not really light, biologically. The SCN reads orders of magnitude, not stops on a dimmer.
Core body temperature as the master switch
Core body temperature is the most reliable readout of circadian phase outside a laboratory melatonin assay. It follows a stereotyped curve: peaks roughly two hours before habitual sleep onset, falls through the night, reaches a minimum (the "core body temperature minimum", usually 2-3 hours before habitual wake), and rises into the morning. The drop in core temperature in the hours before sleep is not incidental to sleep onset — it is mechanistically required for it.
The Kräuchi and Cajochen group at the Centre for Chronobiology in Basel demonstrated this directly. They measured the distal-proximal skin temperature gradient (DPG) — skin temperature at hands and feet relative to skin temperature at the trunk — and showed that the DPG is the single best physiological predictor of sleep onset latency, better than core body temperature, heart rate, melatonin onset, or subjective sleepiness [Kräuchi 1999] [Kräuchi 2000]. The mechanism: heat loss from the body core requires peripheral vasodilation. Distal vasodilation pulls warm blood to the hands and feet, where it dumps heat to the environment, and the resulting fall in core temperature gates sleep onset at the brainstem level.
The practical implication is that anything that promotes distal vasodilation in the late evening accelerates sleep onset. A warm bath 90 minutes before bed (initially counterintuitive — you might expect warming to delay sleep) reliably reduces sleep onset latency by 8-10 minutes in healthy adults; the mechanism is that the warm-bath rebound vasodilates peripheral skin and accelerates core heat loss once the bath ends [Haghayegh 2019]. Cool bedrooms in the 17-19°C range similarly support core heat loss across the night. Bedrooms above 24°C blunt the temperature curve and degrade slow-wave sleep.
DLMO — the cleanest circadian phase marker
DLMO (dim-light melatonin onset) is the gold-standard phase marker in circadian research. The protocol: keep the participant in dim light (<5 lux) starting hours before habitual sleep, sample saliva at 30-60 minute intervals, and identify the time at which melatonin crosses a defined threshold (commonly 3-4 pg/mL in saliva). That crossing time is the DLMO.
For most adults, DLMO occurs roughly 2-3 hours before habitual sleep onset. Habitually late chronotypes have a later DLMO; habitually early chronotypes have an earlier one. Shifts in DLMO across an intervention are the standard way the literature reports phase changes. The clinically actionable fact is that DLMO can be moved by light and by exogenous melatonin in a predictable, dose-dependent way — and that the direction of the move depends entirely on timing relative to DLMO itself.
Exogenous melatonin has its own PRC, roughly the inverse of the light PRC. Melatonin taken in the late afternoon or early evening (before DLMO) phase-advances the circadian system; melatonin taken in the early morning phase-delays it. A low dose (0.3-0.5 mg) taken 5-7 hours before habitual sleep is the protocol with the strongest phase-advance evidence [Burgess 2010]. High doses (3-10 mg) taken at bedtime are common in retail use but produce mostly soporific effects rather than reliable phase shifts, and the supraphysiologic plasma concentrations they generate are not what the endogenous system was designed to handle.
A protocol stack with the strongest RCT support
The interventions below are those with the strongest controlled evidence for improving sleep onset latency, sleep efficiency, or circadian phase alignment in adults without diagnosed circadian disorders.
- Morning outdoor light, within 30-60 minutes of waking, 10-30 minutes duration. The single highest-leverage intervention. Effect is on phase advance, alertness, and downstream evening melatonin onset.
- Evening light reduction starting roughly 2 hours before target sleep. Goal is below ~50 lux at the eye for the final hour. The mechanism is suppressing the light-driven melatonin delay, not "blue light" as a category — wavelength and intensity both matter.
- Bedroom temperature in the 17-19°C range. Supports the core body temperature decline that gates sleep onset.
- Warm bath or shower 60-90 minutes before bed. Accelerates the rebound vasodilation that promotes core heat loss.
- Consistent wake time, including weekends. Wake time anchors the SCN more reliably than bedtime; "social jet lag" — the weekend shift to later sleep — is one of the more consistent population-level predictors of circadian misalignment.
Magnesium glycinate is one of the few supplemental interventions with a reasonable RCT signal in sleep onset specifically — see our piece on the magnesium-sleep RCT evidence for the trial data, and our broader sleep supplement stack review for what else has signal versus what does not. The core point for this article: the circadian inputs above are upstream of every supplement decision. If light and temperature are wrong, no supplement closes the gap.
The studies that produce phase shifts use intensities in the 5,000-10,000 lux range at the eye, sustained for 30 minutes or longer. Commercial "light therapy" devices are commonly specified at 10,000 lux at a defined distance — that specification usually assumes the light source 15-25 cm from the face, which is closer than people typically use. The most reliable way to deliver a phase-advancing dose is outdoor morning light, even on overcast days. The lux numbers cited in indoor protocols underestimate the gap between an indoor lightbox and an outdoor sky.
Phase-shift therapeutics — melatonin, light, sleep
Three contexts require active phase-shifting rather than steady entrainment: jet lag (transmeridian travel), shift work, and delayed sleep-wake phase disorder (DSWPD). The general protocol is the same — combine timed light, timed exogenous melatonin, and gradually shifted sleep windows — but the direction depends on the target.
For eastbound jet lag (where the target time zone is earlier and requires a phase advance): exposure to morning light in the new time zone, low-dose melatonin 5-7 hours before the desired sleep onset for a few days, and a gradually earlier bedtime in the days before travel all contribute. For westbound jet lag (phase delay): evening light and avoidance of morning light in the new zone help the rhythm shift later. The magnitude of shift achievable per day is roughly 1-1.5 hours with optimal protocols, slightly more with phase delays than advances [Eastman 2009].
For shift workers, the goal is usually not full phase reversal — which is rarely achievable across rotating schedules — but partial adaptation that protects performance during night shifts and allows recovery on days off. Bright light during the work shift, dark sunglasses or blue-blocking lenses on the commute home in daylight, and a dark bedroom for daytime sleep are the standard interventions with the most controlled support.
A tiered framework
We do not write protocols. We write frameworks that you adapt to your own constraints, with input from a clinician when sleep complaints are significant.
Outdoor light within the first hour of waking, even briefly. Bedroom in the 17-19°C range. Consistent wake time across weekdays and weekends. These three changes capture most of the available benefit from circadian work for the average adult, and require no supplements, devices, or behavioral overhauls.
On top of the conservative stack: deliberate light reduction in the final two hours before bed, a warm bath or shower 60-90 minutes before sleep, and removal of bright overhead lighting after sunset. This is the protocol that converts a "decent sleeper" into someone whose sleep onset is reliable.
For travel, shift work, or persistent phase issues: 0.3-0.5 mg melatonin timed 5-7 hours pre-sleep for phase advances, a calibrated light source for mornings when outdoor light is not available, and a written phase-shift plan timed against DLMO estimates. This tier benefits from a sleep clinician's input, particularly when the underlying issue may be DSWPD or another specific circadian disorder.
We will not tell you that "blue-blocking glasses" alone fix a circadian rhythm — the intensity of evening light matters as much as wavelength. We will not tell you that 10 mg of bedtime melatonin is equivalent to 0.3 mg timed against DLMO — it is not. We will not tell you that any one intervention substitutes for consistent wake time, because the data say it does not.
References
- Hastings MH, Maywood ES, Brancaccio M. Generation of circadian rhythms in the suprachiasmatic nucleus. Nat Rev Neurosci. 2018;19(8):453-469.
- Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 2002;295(5557):1070-1073.
- Khalsa SBS, et al. A phase response curve to single bright light pulses in human subjects. J Physiol. 2003;549(Pt 3):945-952.
- St Hilaire MA, et al. Human phase response curve to a 1 h pulse of bright white light. J Physiol. 2012;590(13):3035-3045.
- Kräuchi K, et al. Warm feet promote the rapid onset of sleep. Nature. 1999;401(6748):36-37.
- Kräuchi K, et al. Functional link between distal vasodilation and sleep-onset latency? Am J Physiol Regul Integr Comp Physiol. 2000;278(3):R741-748.
- Haghayegh S, et al. Before-bedtime passive body heating by warm shower or bath to improve sleep: A systematic review and meta-analysis. Sleep Med Rev. 2019;46:124-135.
- Burgess HJ, et al. Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg. J Clin Endocrinol Metab. 2010;95(7):3325-3331.
- Eastman CI, Burgess HJ. How to travel the world without jet lag. Sleep Med Clin. 2009;4(2):241-255.
- Czeisler CA, et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science. 1999;284(5423):2177-2181.
- Wright KP Jr, et al. Entrainment of the human circadian clock to the natural light-dark cycle. Curr Biol. 2013;23(16):1554-1558.